Pre-adsorption of antibodies enables targeting of nanocarriers despite a biomolecular corona
- PMID: 29915272
- DOI: 10.1038/s41565-018-0171-6
Pre-adsorption of antibodies enables targeting of nanocarriers despite a biomolecular corona
Abstract
To promote drug delivery to exact sites and cell types, the surface of nanocarriers is functionalized with targeting antibodies or ligands, typically coupled by covalent chemistry. Once the nanocarrier is exposed to biological fluid such as plasma, however, its surface is inevitably covered with various biomolecules forming the protein corona, which masks the targeting ability of the nanoparticle. Here, we show that we can use a pre-adsorption process to attach targeting antibodies to the surface of the nanocarrier. Pre-adsorbed antibodies remain functional and are not completely exchanged or covered by the biomolecular corona, whereas coupled antibodies are more affected by this shielding. We conclude that pre-adsorption is potentially a versatile, efficient and rapid method of attaching targeting moieties to the surface of nanocarriers.
Comment in
-
Antibody orientation determines corona mistargeting capability.Nat Nanotechnol. 2018 Sep;13(9):775-776. doi: 10.1038/s41565-018-0147-6. Nat Nanotechnol. 2018. PMID: 29915270 No abstract available.
Similar articles
-
Carbohydrate-Based Nanocarriers Exhibiting Specific Cell Targeting with Minimum Influence from the Protein Corona.Angew Chem Int Ed Engl. 2015 Jun 15;54(25):7436-40. doi: 10.1002/anie.201502398. Epub 2015 May 4. Angew Chem Int Ed Engl. 2015. PMID: 25940402
-
Phosphonylation Controls the Protein Corona of Multifunctional Polyglycerol-Modified Nanocarriers.Macromol Biosci. 2019 May;19(5):e1800468. doi: 10.1002/mabi.201800468. Epub 2019 Mar 26. Macromol Biosci. 2019. PMID: 30913379
-
Timing of Heparin Addition to the Biomolecular Corona Influences the Cellular Uptake of Nanocarriers.Biomacromolecules. 2019 Oct 14;20(10):3724-3732. doi: 10.1021/acs.biomac.9b00777. Epub 2019 Sep 6. Biomacromolecules. 2019. PMID: 31449399
-
Controlling the Stealth Effect of Nanocarriers through Understanding the Protein Corona.Angew Chem Int Ed Engl. 2016 Jul 25;55(31):8806-15. doi: 10.1002/anie.201602233. Epub 2016 Jun 15. Angew Chem Int Ed Engl. 2016. PMID: 27303916 Review.
-
How Corona Formation Impacts Nanomaterials as Drug Carriers.Mol Pharm. 2020 Mar 2;17(3):725-737. doi: 10.1021/acs.molpharmaceut.9b01111. Epub 2020 Jan 24. Mol Pharm. 2020. PMID: 31939673 Review.
Cited by
-
Nanoscale Technologies for Prevention and Treatment of Heart Failure: Challenges and Opportunities.Chem Rev. 2019 Nov 13;119(21):11352-11390. doi: 10.1021/acs.chemrev.8b00323. Epub 2019 Sep 6. Chem Rev. 2019. PMID: 31490059 Free PMC article. Review.
-
CRISPR/Cas9 Delivery Mediated with Hydroxyl-Rich Nanosystems for Gene Editing in Aorta.Adv Sci (Weinh). 2019 Apr 20;6(12):1900386. doi: 10.1002/advs.201900386. eCollection 2019 Jun 19. Adv Sci (Weinh). 2019. PMID: 31380173 Free PMC article.
-
Antibody-Functionalized Carnauba Wax Nanoparticles to Target Breast Cancer Cells.ACS Appl Bio Mater. 2022 Feb 21;5(2):622-629. doi: 10.1021/acsabm.1c01090. Epub 2022 Jan 3. ACS Appl Bio Mater. 2022. PMID: 35014837 Free PMC article.
-
Nanoscale characterization of the biomolecular corona by cryo-electron microscopy, cryo-electron tomography, and image simulation.Nat Commun. 2021 Jan 25;12(1):573. doi: 10.1038/s41467-020-20884-9. Nat Commun. 2021. PMID: 33495475 Free PMC article.
-
Distinct Proteins in Protein Corona of Nanoparticles Represent a Promising Venue for Endogenous Targeting - Part II: In vitro and in vivo Kinetics Study.Int J Nanomedicine. 2020 Nov 30;15:9539-9556. doi: 10.2147/IJN.S273721. eCollection 2020. Int J Nanomedicine. 2020. PMID: 33299308 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources